Inloggen
E-mail
Wachtwoord
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON
  1. Homepagina
  2. Aandelen
  3. BelgiŽ
  4. Euronext Bruxelles
  5. Acacia Pharma Group plc
  6. Nieuws
  7. Persberichten
    ACPH   GB00BYWF9Y76

ACACIA PHARMA GROUP PLC

(ACPH)
Real-time koersen. Real Time Euronext Bruxelles - 24/06 17:35:14
2.015 EUR   -1.71%
18/06Brussel dieper in het rood
AM
07/06Brussel herwint terrein
AM
27/05Brusselse beurs fractioneel lager geopend
AM
OverzichtKoersenGrafiekenNieuwsRatingenAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtNieuwsAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Communiquťs de presse de la sociťtť ACACIA PHARMA GROUP PLC
01/06ACACIA PHARMA† : Corporate Presentation – Jefferies Healthcare Conference,..
PU
25/05ACACIA PHARMA GROUP PLC : Notice of Annual General Meeting
AQ
25/05ACACIA PHARMA† : to Participate in Jefferies Virtual Healthcare Conference
AQ
19/05ACACIA PHARMA† : Appoints Debra Hussain as Chief Commercial Officer
AQ
04/05ACACIA PHARMA† : Announces Early Repayment of Loan Facility from Hercules Techno..
PU
04/05ACACIA PHARMA† : Announces Early Repayment of Loan Facility from Hercules Techno..
AQ
21/04ACACIA PHARMA† : Becomes New Industry Supporter of the American Society of Anest..
AQ
31/03ACACIA PHARMA† : Publication of Annual Report and Financial Statements for the Y..
AQ
30/03ACACIA PHARMA† : Publication of Annual Report and Financial Statements for the Y..
PU
30/03ACACIA PHARMA† : Publication of Annual Report 2020
AQ
30/03ACACIA PHARMA† : Annual Report and Financial Statements for the Year ended 31 De..
PU
29/03COSMO PHARMACEUTICALS N† : Full-year report 2020
AQ
29/03ACACIA PHARMA† : Presentation of Results for the Year Ended 31 Dec 2020
PU
29/03ACACIA PHARMA† : 2020 Results Webcast and Conference Call
PU
29/03ACACIA PHARMA† : Results for the year ended 31 December 2020
AQ
18/03ACACIA PHARMA† : to Report its Results for the Full Year 2020 and Provide a Busi..
PU
18/03ACACIA PHARMA† : Notice of Full Year 2020 Results
AQ
05/03ACACIA PHARMA† : Transparency Notification
PU
26/02ACACIA PHARMA† : Transparency Notification
AQ
26/02ACACIA PHARMA† : Issue of Equity on Exercise of Options/Vesting of Performance S..
AQ
23/02ACACIA PHARMA† : Admission to Trading on Euronext Brussels
AQ
22/02ACACIA PHARMA GROUP PLC† : - Results of Placing, EUR 27 million raised to Invest..
AQ
19/02ACACIA PHARMA† : Change of EU home Member State
AQ
19/02ACACIA PHARMA† : Results of Placing – EUR 27 million Raised to Invest Furt..
AQ
18/02ACACIA PHARMA† : Proposed Capital Raising by way of a Placing of New Ordinary Sh..
AQ
18/02ACACIA PHARMA† : Change of EU home Member State
PU
18/02ACACIA PHARMA† : †Change of EU home Member State
AQ
12/02ACACIA PHARMA† : Issue of Equity on Exercise of Options/Vesting of Performance S..
PU
04/02ACACIA PHARMA† : Issue of Equity on Exercise of Options/Vesting of Performance S..
AQ
29/01ACACIA PHARMA† : Launches BYFAVO in the United States for Procedural Sedation in..
AQ
28/01ACACIA PHARMA† : Corporate Presentation – Degroof Petercam Virtual Healthc..
PU
28/01ACACIA PHARMA† : Launches BYFAVO™ (remimazolam) in the United States for P..
PU
28/01ACACIA PHARMA† : Launches BYFAVO™ (remimazolam) in the United States for P..
AQ
21/01ACACIA PHARMA† : to present at the Upcoming Degroof Petercam Virtual Healthcare ..
AQ
20/01ACACIA PHARMA† : Issue of Equity on Exercise of Options/Vesting of Performance S..
AQ
20/01ACACIA PHARMA† : wins BEL Small Company of the Year for the second consecutive y..
AQ
2020ACACIA PHARMA† : Announces Amendment of its Investment Agreement with Cosmo Phar..
PU
2020ACACIA PHARMA† : Holding(s) in Company
AQ
2020ACACIA PHARMA† : Admission to Trading on Euronext Brussels
AQ
2020ACACIA PHARMA† : Publication of Supplementary Prospectus
AQ
2020COSMO PHARMACEUTICALS N† : Acacia Pharma Announces Amendment of its Investment A..
AQ
2020CORRECTION : Acacia Pharma Announces Amendment of its Investment Agreement with ..
AQ
2020ACACIA PHARMA† : Director/PDMR Shareholding
PU
2020ACACIA PHARMA† : Issue of Shares to Employee Benefit Trust
PU
2020ACACIA PHARMA† : Director/PDMR Shareholding
AQ
2020ACACIA PHARMA† : Issue of Shares to Employee Benefit Trust
AQ
2020COSMO PHARMACEUTICALS N† : Acacia Pharma completes drawdown from EUR25 million l..
AQ
2020ACACIA PHARMA† : Corporate Presentation October 2020
PU
2020ACACIA PHARMA† : completes drawdown from Ä25 million loan facility from Cosmo Ph..
PU
2020ACACIA PHARMA† : completes drawdown from Ä25 million loan facility from Cosmo Ph..
AQ
2020ACACIA PHARMA† : announces BYFAVO, its Newly Approved Product for Procedural Sed..
AQ
2020ACACIA PHARMA† : announces BYFAVO™ (remimazolam), its Newly Approved Produ..
PU
2020ACACIA PHARMA† : announces BYFAVO™ (remimazolam), its Newly Approved Produ..
AQ
2020ACACIA PHARMA† : BARHEMSYSģ (amisulpride injection) Launched and Commercially Av..
PU
2020ACACIA PHARMA† : BARHEMSYS Launched and Commercially Available in the US for the..
AQ
2020ACACIA PHARMA† : BARHEMSYSģ (amisulpride injection) Launched in the US for the T..
AQ
2020ACACIA PHARMA† : Holding(s) in Company
AQ
2020ACACIA PHARMA† : Admission to Trading on Euronext Brussels
AQ
2020ACACIA PHARMA† : Results of Placing
AQ
2020ACACIA PHARMA† : Advances Preparations for US Launch of BARHEMSYSģ
PU
2020ACACIA PHARMA† : Interim Results for the Six Months ended 30 June 2020
AQ
2020ACACIA PHARMA† : Publication of Prospectus
AQ
2020ACACIA PHARMA† : Results of Placing
AQ
2020ACACIA PHARMA† : Proposed Capital Raising by way of a Placing of New Ordinary Sh..
AQ
2020ACACIA PHARMA† : Advances Preparations for US Launch of BARHEMSYS
AQ
2020ACACIA PHARMA† : Advances Preparations for US Launch of BARHEMSYSģ
AQ
2020ACACIA PHARMA† : Holding(s) in Company
AQ
2020ACACIA PHARMA† : Issue of Equity pursuant to Sub-Licensing Agreement With Cosmo ..
AQ
2020ACACIA PHARMA† : Assigned US License for BYFAVO™ (remimazolam) by Cosmo Ph..
AQ
2020Acacia Pharma Announces US FDA Approval of BYFAVO for injection for the Induc..
AQ
2020ACACIA PHARMA† : Announces US FDA Approval of BYFAVO™ (remimazolam) for in..
PU
2020ACACIA PHARMA† : Announces US FDA Approval of BYFAVO™ (remimazolam) for in..
AQ
2020TR-1 : Standard form for notification of major holdings
AQ
2020ACACIA PHARMA† : Announces Debt for Equity Swap with Cosmo Pharmaceuticals
AQ
2020ACACIA PHARMA† : Issue of Equity on Exercise of Options/Vesting of Performance S..
AQ
1  2Volgende
Volgende evenement op ACACIA PHARMA GROUP PLC
Komende gebeurtenissen in de sector